Is higher serum cholesterol associated with altered tendon structure or tendon pain? A systematic review

British Journal of Sports Medicine

Volumn 49, Issue 23, 2015, Pages 1504-1509

  Tilley, Benjamin J ^a   Cook, Jill L ^a,b   Docking, Sean I ^a,b   Gaida, James E ^a,c  

^a MONASH UNIVERSITY   (Australia)

^b UNIVERSITY OF BALLARAT   (Australia)

^c UNIVERSITY OF CANBERRA   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLESTEROL; TRIACYLGLYCEROL;

BLOOD; FEMALE; HUMAN; LIPID METABOLISM; MALE; METABOLISM; MUSCULOSKELETAL PAIN; PAIN MEASUREMENT; PATHOLOGY; PHYSIOLOGY; SEXUAL DEVELOPMENT; TENDINITIS; TENDON; TENDON INJURY;

CHOLESTEROL; FEMALE; HUMANS; LIPID METABOLISM; MALE; MUSCULOSKELETAL PAIN; PAIN MEASUREMENT; SEX CHARACTERISTICS; TENDINOPATHY; TENDON INJURIES; TENDONS; TRIGLYCERIDES;

EID: 84946807292     PISSN: 03063674     EISSN: 14730480     Source Type: Journal    
DOI: 10.1136/bjsports-2015-095100     Document Type: Review

References (59)

1. Cook JL, Khan KM, Maffulli N, et al. Overuse tendinosis, not tendinitis part 2: applying the new approach to patellar tendinopathy. Physician Sportsmed 2000;28:31-46.
2. Khan KM, Cook JL, Taunton JE, et al. Overuse tendinosis, not tendinitis part 1: a new paradigm for a difficult clinical problem. Physician Sportsmed 2000;28:38-48.
3. Kujala UM, Sarna S, Kaprio J. Cumulative incidence of Achilles tendon rupture and tendinopathy in male former elite athletes. Clin J Sport Med 2005;15:133-5.
4. Rolf C, Movin T. Etiology, histopathology, and outcome of surgery in achillodynia. Foot Ankle Int 1997;18:565-9.
5. Holmes GB, Lin J. Etiologic factors associated with symptomatic Achilles tendinopathy. Foot Ankle Int 2006;27:952-9.
6. Gaida JE, Alfredson L, Kiss ZS, et al. Dyslipidemia in Achilles tendinopathy is characteristic of insulin resistance. Med Sci Sports Exerc 2009;41:1194-7.
7. Gaida JE, Ashe MC, Bass SL, et al. Is adiposity an under-recognized risk factor for tendinopathy? A systematic review. Arthritis Rheum 2009;61:840-9.
8. Abate M, Schiavone C, Di Carlo L, et al. Prevalence of and risk factors for asymptomatic rotator cuff tears in postmenopausal women. Menopause 2014;21:275-80.
9. Gordon T, Castelli WP, Hjortland MC, et al. High density lipoprotein as a protective factor against coronary heart disease. The Framingham Study. Am J Med 1977;62:707-14.
10. Adams CW, Bayliss OB, Baker RW, et al. Lipid deposits in ageing human arteries, tendons and fascia. Atherosclerosis 1974;19:429-40.
11. Finlayson R, Woods SJ. Lipid in the Achilles tendon. A comparative study. Atherosclerosis 1975;21:371-89.
12. Jozsa L, Reffy A, Balint JB. The pathogenesis of tendolipomatosis; an electron microscopical study. Int Orthop 1984;7:251-5.
13. Junyent M, Gilabert R, Zambon D, et al. The use of Achilles tendon sonography to distinguish familial hypercholesterolemia from other genetic dyslipidemias. Arterioscler Thromb Vasc Biol 2005;25:2203-8.
14. Tsouli SG, Xydis V, Argyropoulou MI, et al. Regression of Achilles tendon thickness after statin treatment in patients with familial hypercholesterolemia: an ultrasonographic study. Atherosclerosis 2009;205:151-5.
15. Beeharry D, Coupe B, Benbow EW, et al. Familial hypercholesterolaemia commonly presents with Achilles tenosynovitis. Ann Rheum Dis 2006;65:312-15.
16. Holven KB, Narverud I, Lindvig HW, et al. Subjects with familial hypercholesterolemia are characterized by an inflammatory phenotype despite longterm intensive cholesterol lowering treatment. Atherosclerosis 2014;233:561-7.
17. Moore KJ, Tabas I. Macrophages in the pathogenesis of atherosclerosis. Cell 2011;145:341-55.
18. Williams KJ, Tabas I. The response-to-retention hypothesis of early atherogenesis. Arterioscler Thromb Vasc Biol 1995;15:551-61.
19. Gustafsson M, Boren J. Mechanism of lipoprotein retention by the extracellular matrix. Curr Opin Lipidol 2004;15:505-14.
20. Rader DJ, Pure E. Lipoproteins, macrophage function, and atherosclerosis: beyond the foam cell? Cell Metab 2005;1:223-30.
21. Tabas I. Consequences of cellular cholesterol accumulation: basic concepts and physiological implications. J Clin Invest 2002;110:905-11.
22. Tall AR, Yvan-Charvet L. Cholesterol, inflammation and innate immunity. Nat Rev Immunol 2015;15:104-16.
23. Kragsnaes MS, Fredberg U, Stribolt K, et al. Stereological quantification of immune-competent cells in baseline biopsy specimens from Achilles tendons: results from patients with chronic tendinopathy followed for more than 4 years. Am J Sports Med 2014;42:2435-45.
24. Scott A, Lian O, Bahr R, et al. Increased mast cell numbers in human patellar tendinosis: correlation with symptom duration and vascular hyperplasia. Br J Sports Med 2008;42:753-7.
25. Fearon AM, Twin J, Dahlstrom JE, et al. Increased substance P expression in the trochanteric bursa of patients with greater trochanteric pain syndrome. Rheumatol Int 2014;34:1441-8.
26. Gaida JE, Bagge J, Purdam C, et al. Evidence of the TNF-alpha system in the human Achilles tendon: expression of TNF-alpha and TNF receptor at both protein and mRNA levels in the tenocytes. Cells Tissues Organs 2012;196:339-52.
27. Medzhitov R. Origin and physiological roles of inflammation. Nature 2008;454:428-35.
28. Mathiak G, Wening JV, Mathiak M, et al. Serum cholesterol is elevated in patients with Achilles tendon ruptures. Arch Orthop Trauma Surg 1999;119:280-4.
29. Ozgurtas T, Yildiz C, Serdar M, et al. Is high concentration of serum lipids a risk factor for Achilles tendon rupture? Clin Chim Acta 2003;331:25-8.
30. Franssen R, Monajemi H, Stroes ES, et al. Obesity and dyslipidemia. Endocrinol Metab Clin North Am 2008;37:623-33, viii.
31. Downs SH, Black N. The feasibility of creating a checklist for the assessment of the methodological quality both of randomised and non-randomised studies of health care interventions. J Epidemiol Community Health 1998;52:377-84.
32. Abboud JA, Kim JS. The effect of hypercholesterolemia on rotator cuff disease. Clin Orthop Relat Res 2010;468:1493-7.
33. Beri A, Dwamena FC, Dwamena BA. Association between statin therapy and tendon rupture: a case-control study. J Cardiovasc Pharmacol 2009;53:401-4.
34. Longo UG, Franceschi F, Spiezia F, et al. Triglycerides and total serum cholesterol in rotator cuff tears: do they matter? Br J Sports Med 2010;44:948-51.
35. Gattereau A, Davignon J, Langelier M, et al. An improved radiological method for the evaluation of Achilles tendon xanthomatosis. CMAJ 1973;108:39-42.
36. Klemp P, Halland AM, Majoos FL, et al. Musculoskeletal manifestations in hyperlipidaemia: a controlled study. Ann Rheum Dis 1993;52:44-8.
37. Kwak M, Yoon S, Cho Y, et al. The correlation between Achilles tendon thickness and cardiovascular risk factors. J Lipid Atheroscler 2013;2:77-83.
38. Descamps OS, Leysen X, Van Leuven F, et al. The use of Achilles tendon ultrasonography for the diagnosis of familial hypercholesterolemia. Atherosclerosis 2001;157:514-18.
39. Durrington PN, Adams JE, Beastall MD. The assessment of Achilles tendon size in primary hypercholesterolaemia by computed tomography. Atherosclerosis 1982;45:345-58.
40. Mabuchi H, Ito S, Haba T. Discrimination of familial hypercholesterolemia and secondary hypercholesterolemia by Achilles' tendon thickness. Atherosclerosis 1977;28:61-7.
41. Mabuchi H, Tatami R, Haba T, et al. Achilles tendon thickness and ischemic heart disease in familial hypercholesterolemia. Metabolism 1978;27:1672-9.
42. Yuzawa K, Yamakawa K, Tohno E, et al. An ultrasonographic method for detection of Achilles tendon xanthomas in familial hypercholesterolemia. Atherosclerosis 1989;75:211-18.
43. Rechardt M, Shiri R, Lindholm H, et al. Associations of metabolic factors and adipokines with pain in incipient upper extremity soft tissue disorders: a cross-sectional study. BMJ Open 2013;3:e003036.
44. Borenstein M, Hedges L, Higgins J, et al. Introduction to meta-analysis. John Wiley & Sons, 2008.
45. Hamburg NM, McMackin CJ, Huang AL, et al. Physical inactivity rapidly induces insulin resistance and microvascular dysfunction in healthy volunteers. Arterioscler Thromb Vasc Biol 2007;27:2650-6.
46. Olsen RH, Krogh-Madsen R, Thomsen C, et al. Metabolic responses to reduced daily steps in healthy nonexercising men. JAMA 2008;299:1261-3.
47. Yamakawa K, Yanagi H, Saku K, et al. Family studies of the LDL receptor gene of relatively severe heriditary hypercholesterolemia associated with Achilles tendon xanthomas. Hum Genet 1991;86:445-9.
48. Beason DP, Abboud JA, Kuntz AF, et al. Cumulative effects of hypercholesterolemia on tendon biomechanics in a mouse model. J Orthop Res 2011;29:380-3.
49. Beason DP, Hsu JE, Marshall SM, et al. Hypercholesterolemia increases supraspinatus tendon stiffness and elastic modulus across multiple species. J Shoulder Elbow Surg 2013;22:681-6.
50. de Oliveira LP, Vieira CP, Da Re Guerra F, et al. Statins induce biochemical changes in the Achilles tendon after chronic treatment. Toxicology 2013;311:162-8.
51. Pasternak B, Schepull T, Eliasson P, et al. Elevation of systemic matrix metalloproteinases 2 and 7 and tissue inhibitor of metalloproteinase 2 in patients with a history of Achilles tendon rupture: pilot study. Br J Sports Med 2010;44:669-72.
52. Ku D. Blood flow in arteries. Annu Rev Fluid Mechanics 1997;29:399-434.
53. Manley G, Hawksworth J. Distribution of mucopolysaccharides in the human vascular tree. Nature 1965;206:1152-3.
54. Linton MF, Fazio S. Macrophages, inflammation, and atherosclerosis. Int J Obes Relat Metab Disord 2003;27(Suppl 3):S35-40.
55. Benjamin M, Qin S, Ralphs JR. Fibrocartilage associated with human tendons and their pulleys. J Anat 1995;187(Pt 3):625-33.
56. Adams CW, Bayliss OB. Acid mucosubstances underlying lipid deposits in ageing tendons and atherosclerotic arteries. Atherosclerosis 1973;18:191-5.
57. Volker W, Schmidt A, Oortmann W, et al. Mapping of proteoglycans in atherosclerotic lesions. Eur Heart J 1990;11(Suppl E):29-40.
58. Egger M, Zellweger-Zahner T, Schneider M, et al. Language bias in randomised controlled trials published in English and German. Lancet 1997;350:326-9.
59. Langsted A, Freiberg JJ, Nordestgaard BG. Fasting and nonfasting lipid levels: influence of normal food intake on lipids, lipoproteins, apolipoproteins, and cardiovascular risk prediction. Circulation 2008;118:2047-56.